Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study [Phase 1, Phase 2]
A randomized, placebo-controlled pilot study evaluating prednisone for refractory restless legs syndrome (Phase 1/Phase 2); the trial is cur…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Effect of Progressive Muscle Relaxation Exercises in Menopausal Women Experiencing RLS. [NA]
A completed clinical trial evaluated progressive muscle relaxation exercises for menopausal women with Restless Legs Syndrome.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction [NA]
Completed clinical trial results for noninvasive peripheral nerve stimulation to treat Restless Legs Syndrome during opioid reduction were p…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) [NA]
The RESTFUL study, sponsored by Noctrix Health, evaluated noninvasive peripheral nerve stimulation for medication-refractory primary Restles…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS [NA]
Extension study evaluating the NTX100 neuromodulation system for medication-refractory primary Restless Legs Syndrome has completed, with re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a cannabidiolic acid topical cream for Restless Legs Syndrome; the study is currently active but no…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: PMR Versus MLD on RLS and Sleep Quality in Hemodialysis Patients [NA]
A completed clinical trial comparing PMR vs MLD to assess effects on restless legs syndrome symptoms and sleep quality in patients undergoin…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients [NA]
A completed clinical trial comparing exercise training to ropinirole for treating restless legs syndrome in patients undergoing hemodialysis…
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder [Phase 4]
Phase 4 trial evaluating different frequencies of oral iron dosing in children with Restless Legs Syndrome and Periodic Limb Movement Disord…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Gut Microbiota and Bacterial Translocation in Restless Legs Syndrome
Clinical trial update investigating gut microbiota and bacterial translocation in Restless Legs Syndrome (NCT05985421).
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients
This completed study compares medium cut-off dialyzers to high-flux dialyzers in prevalent hemodialysis patients. It assesses effects on cli…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: The Effect of Kinesio Taping and Manual Lymph Drainage on Pregnant Women With Restless Legs Syndrome [NA]
A clinical trial is recruiting to assess the effects of Kinesio Taping and Manual Lymph Drainage on Restless Legs Syndrome in pregnant women…
-
FDA approval · 2024-05-06FDA Approved: ROPINIROLE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for ropinirole from Accord Healthcare Inc., indicating the generic product's approval under an ANDA.
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Executive Dysfunction in Restless Legs Syndrome: Clinical Correlates and Outcome After Therapeutic Management [NA]
A clinical trial investigating executive dysfunction in restless legs syndrome, examining clinical correlates and outcomes after therapeutic…
-
EMA approval · 2024-05-02EMA Authorised: Mirapexin (pramipexole dihydrochloride monohydrate) — Boehringer Ingelheim International GmbH
The European Medicines Agency authorized Mirapexin (pramipexole dihydrochloride monohydrate) for restless legs syndrome and Parkinson's dise…
-
EMA approval · 2024-04-25EMA Authorised: Sifrol (pramipexole dihydrochloride monohydrate) — Boehringer Ingelheim International GmbH
The EMA authorized Sifrol (pramipexole dihydrochloride monohydrate) from Boehringer Ingelheim for restless legs syndrome and Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome [Phase 2]
Phase 2 trial of istradefylline (KW-6002) for restless legs syndrome has completed.
-
EMA withdrawal · 2024-03-11EMA Withdrawn: Pramipexole Accord (pramipexole dihydrochloride monohydrate) — Accord Healthcare S.L.U.
Withdrawn EMA decision for Pramipexole Accord (pramipexole dihydrochloride monohydrate) by Accord Healthcare S.L.U., affecting Parkinson's d…
-
FDA approval · 2024-03-05FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride from Aurobindo Pharma Limited, enabling the generic product for …
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia [Phase 4]
Phase 4 trial evaluating suvorexant for efficacy in patients with effectively treated restless legs syndrome and persistent chronic insomnia…
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome [Phase 3]
A Phase 3 follow-up study of rotigotine patch in adolescents with Restless Legs Syndrome was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause [Phase 3]
Phase 3 clinical trial of a rotigotine patch in adolescents with Restless Legs Syndrome was terminated; results have been posted.
-
CLINICAL_TRIALS withdrawal · 2023-10-25Clinical Trial Update: Butrans for Treatment of Restless Legs Syndrome [Phase 4]
Phase 4 clinical trial of Butrans for restless legs syndrome has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Spinal Cord Stimulation for Restless Legs Syndrome [NA]
A completed clinical trial investigated spinal cord stimulation as a treatment for Restless Legs Syndrome, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA) [Phase 2]
Phase 2 randomized trial comparing intravenous vs oral iron for restless legs syndrome with iron deficiency anemia completed; results posted…